Cross-Platform Identification and Validation of Uveal Melanoma Vitreous Protein Biomarkers
Investigative Opthalmology & Visual Science · 2023
DOI: 10.1167/iovs.64.14.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, 2023. Verfasst von Gabriel Velez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Surgery Laboratory, Stanford University, Palo Alto, California, United States. Hauptthemen laut MEDLINE: Uveal Neoplasms, Melanoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Surgery Laboratory, Stanford University, Palo Alto, California, United States.
- Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California, United States.
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
- Veterans Affairs Palo Alto Health Care System, Palo Alto, California, United States.
Förderung
- NEI NIH HHS
Zitieren
APA
Velez, G., Wolf, J., Dufour, A., Mruthyunjaya, P., & Mahajan, V. B. (2023). Cross-Platform Identification and Validation of Uveal Melanoma Vitreous Protein Biomarkers. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.14.14
Vancouver
Velez G, Wolf J, Dufour A, Mruthyunjaya P, Mahajan VB. Cross-Platform Identification and Validation of Uveal Melanoma Vitreous Protein Biomarkers. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.14.14
BibTeX
@article{Velez2023,
author = {Velez, Gabriel and Wolf, Julian and Dufour, Antoine and Mruthyunjaya, Prithvi and Mahajan, Vinit B},
title = {Cross-Platform Identification and Validation of Uveal Melanoma Vitreous Protein Biomarkers},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
doi = {10.1167/iovs.64.14.14}
}
EUVIMED